UZ Antwerpen

Antwerp 2650

3 studies enrolling now · 18 studies all time

What they study most

Alpha1-Antitrypsin Deficiency, Aneurysmal Subarachnoid Hemorrhage, Breast Cancer, Catecholamine-resistant Hypotension (CRH), Coagulopathy, Complex Cryptoglandular Fistula, Complex Perianal Fistula, Crohns Disease, Cryptogenic Ischemic Stroke, Cryptogenic Symptomatic Transient Ischemic Attack, Cystic Fibrosis, Distributive Shock

Studies at this site

• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• A Study of Surgical Interventions in Fistulizing Conditions — Completed
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis — Completed
• Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours — Completed
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer — Completed
• Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour — Completed
• A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity — Completed
• Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy — Completed
• Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients — Completed
• A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis — Completed
• Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
• A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed
• Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke — Completed